Protocol summary

Study aim
Comparison of the effectiveness of atropine-neostigmine mixture injection and ondansetron injection in preventing headache after cesarean section under spinal anesthesia
Design
A clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 60 patients. Lottery and sealed envelopes are used for randomization.
Settings and conduct
This is a randomized double-blind clinical trial that will be performed on 60 patients undergoing cesarean section under spinal anesthesia at Beheshti Hospital in Isfahan; After the approval of the university ethics committee and obtaining the patients' consent, the patients entered the groups by random allocation. In each group, the desired intervention is applied and the patient's clinical signs and existing complications are reviewed and recorded. The person who is performing the intervention would be different from the evaluator and they do not know the type of intervention. In spite of the fact that Patients are aware of the study, they are not aware of the type of intervention so they are all blind.
Participants/Inclusion and exclusion criteria
Inclusion criteria: 18 to 45 years old pregnant woman undergoing cesarean section under spinal anesthesia, anesthesia ASA class I and II, and patient informed consent. Exclusion criteria: history of coagulation diseases, presence of nerve damage in limbs, spine, and CNS, history of spinal surgery, MS, and Migraine history.
Intervention groups
Intervention group A: They receive a mixture containing 20 µg/kg Neostigmine and 10µg/kg Atropine 15 minutes before the spinal anesthesia. Intervention group B: They Receive 4 mg of ondansetron 15 minutes before spinal anesthesia.Control group C: They receive 5 ml of distilled water 15 minutes before the spinal.
Main outcome variables
The headache after spinal anesthesia

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20160307026950N39
Registration date: 2022-01-13, 1400/10/23
Registration timing: prospective

Last update: 2022-01-13, 1400/10/23
Update count: 0
Registration date
2022-01-13, 1400/10/23
Registrant information
Name
Behzad Nazemroaya
Name of organization / entity
Isfahan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 31 3212 3543
Email address
behzad_nazem@med.mui.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-01-21, 1400/11/01
Expected recruitment end date
2022-03-21, 1401/01/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effectiveness of Atropine-Neostigmine mixture and Ondansetron injection in preventing headache after Cesarean section under spinal anesthesia
Public title
The effect of Atropine-Neostigmine mixture and Ondansetron on headache after Cesarean section under spinal anesthesia
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Pregnant woman candidate for cesarean section under spinal anesthesia Age 18 to 45 years ASA class I and II Patient consent to study
Exclusion criteria:
Consumption of anticoagulants Existence of nerve damage in limbs, spine and CNS Having coagulation diseases History of spinal surgery, spinal stenosis and MS Having heart conduction disorders Have a history of migraine headaches
Age
From 18 years old to 45 years old
Gender
Female
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
This is a simple randomized clinical trial in which individuals enter study groups by lottery; The drugs are placed in the desired number in sealed opaque and uniformly sealed bags. Each of the codes is also written on a piece of paper, folded, and placed inside a box. After entering the operating room, each patient takes one of the papers out of the box. Which is applied to the patient. This continues until the end of the paperwork so that the number of patients in the desired volume in the groups.
Blinding (investigator's opinion)
Double blinded
Blinding description
This is a double-blind clinical trial; In this way, before obtaining consent, patients are studied but do not know which group they will be in and therefore are blind. Also, the nurse who injects the drug and the researcher who records the patient's symptoms do not know the type of drug and are blind.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Isfahan University of Medical Sciences
Street address
Isfahan University of Medical Sciences, Hezar Jarib street, Azadi square, Isfahan
City
Isfahan
Province
Isfehan
Postal code
8174673461
Approval date
2021-04-07, 1400/01/18
Ethics committee reference number
IR.MUI.MED.REC.1400.009

Health conditions studied

1

Description of health condition studied
Headache after spinal anesthesia in cesarean
ICD-10 code
O29
ICD-10 code description
Complications of anesthesia during pregnancy

Primary outcomes

1

Description
The headache after spinal anesthesia in Cesarean
Timepoint
Patients are followed up for headaches for up to seven days after the spinal block. In case of headache in the first 24 hours every 6 hours and then daily, its amount is measured by VAS scale.
Method of measurement
VAS Pain Intensity Scale

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group A: In this group, eligible patients, after being placed on a surgical bed and monitoring connection, receive about 2cc/kg/hr serum 1/3-2/3 then 10µg/kg Atropine and 20µg/kg Neostigminr will be injected 15 minutes before the spinal. Then the patient will be positioned in a seating or lateral and spinal anesthesia will be performed. Then patients receive 4-6 liters of oxygen per minute through a face mask and after sensory and motor block surgery will perform. During the operation and in recovery, the patient is monitored for vital signs and related complications.
Category
Prevention

2

Description
Intervention group B: In this group, eligible patients, after being placed on a surgical bed and monitoring connection, receive 2cc/kg/hr of 1/3-2/3 serum, then they are given 4 mg of Ondansetron 15 minutes before the spinal Is injected. Then the patient will be positioned in a seating or lateral and spinal anesthesia will be performed. Then patients receive 4-6 liters of oxygen per minute through a face mask and after sensory and motor block surgery will perform. During the operation and in recovery, the patient is monitored for vital signs and related complications.
Category
Prevention

3

Description
Control group C: In this group, eligible patients, after being placed on a surgical bed and monitoring connection, receive 2cc/kg/hr of serum 1/3-2/3, then they are given 5 ml of distilled water as a placebo 15 minutes before Spinal injection is performed. Then patients receive 4-6 liters of oxygen per minute through a face mask and after sensory and motor block surgery will perform. During the operation and in recovery, the patient is monitored for vital signs and related complications.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Isfahan Shahid Beheshti Hospital
Full name of responsible person
Behzad Nazemroaya
Street address
Shahid Beheshti Hospital , Ostad Motahhari St. , felezi Bridge , Isfahan
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3236 7001
Email
beheshti@mui.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Shaghayegh Haghjoo
Street address
Vice Chancellor for Research, Building4, Isfahan University Of Medical Sciences, Hezarjirib St.
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 0048
Email
research@mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Esfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Behzad Nazemroaya
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Ostandari
City
Isfahan
Province
Isfehan
Postal code
8146713543
Phone
+98 31 3224 7233
Email
b.nazemroaya@khuisf.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Behzad Nazemroaya
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Ostandari
City
Isfahan
Province
Isfehan
Postal code
8146713543
Phone
+98 31 3224 7233
Email
b.nazemroaya@khuisf.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Behzad Nazemroaya
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Ostandari
City
Isfahan
Province
Isfehan
Postal code
8146713543
Phone
+98 31 3224 7233
Email
b.nazemroaya@khuisf.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...